30 Day FRN

33689

Federal Register / Vol. 85, No. 106 / Tuesday, June 2, 2020 / Notices
collaborations and training of providers.
In addition to meeting the goal of
accountability to Congress, clients,
public and community groups, and the
general public, information collected in
the DSR is critical for HRSA and for
recipients to help assess the status of
existing HIV-related health service
delivery systems.
Likely Respondents: Accredited
schools of dentistry and other
accredited dental education programs,
such as dental hygiene programs or
those sponsored by a school of

dentistry, a hospital, or a public or
private institution that offers
postdoctoral training in the specialties
of dentistry, advanced education in
general dentistry, or a dental general
practice residency.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose

of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and respond to a collection of
information; to search data sources; to
complete and review the collection of
information; and to transmit or
otherwise disclose the information. The
total annual burden hours estimated for
this ICR are summarized in the table
below.

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Average
burden per
response
(in hours)

Total
responses

Total burden
hours

Type of respondent

Dental Services Report .......

DRP ....................................
CBDPP ...............................

56
12

1
1

56
12

45
39

2,520
468

Total .............................

.............................................

68

........................

68

........................

2,988

Maria G. Button,
Director, Executive Secretariat.
BILLING CODE 4165–15–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier OS–0990–0438]

Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Teen
Pregnancy Prevention Performance
Measures for FY2020.
Type of Collection: Revision.
OMB No.: 0990–0438.
Abstract: The Office of Population
Affairs (OPA), U.S. Department of
Health and Human Services (HHS), is

SUPPLEMENTARY INFORMATION:

Agency Information Collection
Request. 30-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.

AGENCY:
ACTION:

requesting a revision of the performance
measures for collecting data from new
Teen Pregnancy Prevention Program
grantees to be awarded in FY2020. In
FY2020, OPA expects to award 3-year
TPP cooperative agreements to up to 90
organizations across three funding
announcements. Collection of
performance measures is a requirement
of all TPP grant awards and is included
in the funding announcements. The
measures include dissemination,
partners, training, sustainability, reach,
dosage, fidelity, quality, Tier 1
supportive services referrals,
stakeholder engagement, and Tier 2
project type. To reflect the priorities of
the new funding announcements, some
of the measures and forms have been
revised. The data collection will allow
OPA to comply with federal
accountability and performance
requirements, inform stakeholders of
grantee progress in meeting TPP
program goals, provide OPA with
metrics for monitoring FY2020 TPP
grantees, and facilitate individual
grantees’ continuous quality
improvement efforts within their
projects.
Clearance is requested for three years.
Type of Respondent: TPP grantees and
their staff.

for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT:
Sherrette Funn, [email protected]
or (202) 795–7714. When submitting
comments or requesting information,
please include the document identifier
0990–0438–30D and project title for
reference.

[FR Doc. 2020–11834 Filed 6–1–20; 8:45 am]

In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before July 2, 2020.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
SUMMARY:

khammond on DSKJM1Z7X2PROD with NOTICES

Number of
respondents

Form name

ESTIMATED ANNUALIZED BURDEN TABLE
Number of
respondents

Type of respondent

TPP grantees (partners and sustainability) .....................................................

VerDate Sep<11>2014

20:46 Jun 01, 2020

Jkt 250001

PO 00000

Frm 00070

Fmt 4703

Sfmt 4703

Number
responses per
respondent

90

E:\FR\FM\02JNN1.SGM

2

02JNN1

Average
burden per
response
(in hours)
15/60

Total
burden hours
45

33690

Federal Register / Vol. 85, No. 106 / Tuesday, June 2, 2020 / Notices
ESTIMATED ANNUALIZED BURDEN TABLE—Continued
Number of
respondents

Type of respondent

Average
burden per
response
(in hours)

Total
burden hours

TPP Grantees (training) ...................................................................................
TPP Grantees (dissemination) ........................................................................
TPP Grantees Stakeholder Engagement ........................................................
Tier 1 and Tier 2 Phase II grantees (Reach and Demographics) ...................
Tier 1 and Tier 2 Phase II grantees (Dosage) ................................................
Tier 1 and Tier 2 Phase II grantees (Fidelity and Quality) ..............................
Tier 2 Innovation Network Item .......................................................................
Tier 1 Grantees (Supportive Services) ............................................................

90
90
90
64
64
64
14
54

2
2
2
2
2
2
2
2

15/60
30/60
15/60
3
2
2
15/60
15/60

45
90
45
384
256
256
7
27

Total ..........................................................................................................

90

2

........................

1155

Sherrette A. Funn,
Office of the Secretary, Paperwork Reduction
Act Reports Clearance Officer.
[FR Doc. 2020–11862 Filed 6–1–20; 8:45 am]
BILLING CODE 4150–34–P

National Institutes of Health

[FR Doc. 2020–11804 Filed 6–1–20; 8:45 am]

National Institute on Drug Abuse;
Notice of Closed Meeting

BILLING CODE 4140–01–P

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; HEAL
Initiative: America’s Startups and Small
Businesses Build Technologies to Stop the
Opioid Epidemic.
Date: July 15–16, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neurosciences Center Building, 6001
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Gerald L. McLaughlin,
Ph.D., Scientific Review Officer, Office of
Extramural Policy and Review, National
Institute on Drug Abuse, NIH, Room 4235,
MSC 9550, 6001 Executive Boulevard,
Bethesda, MD 20892–9550, (301) 827–5819,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist

VerDate Sep<11>2014

20:46 Jun 01, 2020

Jkt 250001

Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: May 27, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

khammond on DSKJM1Z7X2PROD with NOTICES

Number
responses per
respondent

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Biomedical Computing and Health
Informatics Study Section.
Date: June 25–26, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Chittari V. Shivakumar,
Ph.D., Scientific Review Officer, National

PO 00000

Frm 00071

Fmt 4703

Sfmt 4703

Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 408–9098, chittari.shivakumar@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business Applications: Drug Discovery and
Development.
Date: June 29–30, 2020.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892, (301) 435–
1180, [email protected].
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Motor Function, Speech and
Rehabilitation Study Section.
Date: June 29–30, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Biao Tian, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3166, MSC 7848, Bethesda, MD
20892, (301) 402–4411, [email protected].
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group;
Cancer Molecular Pathobiology Study
Section.
Date: June 29–30, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I,I 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Manzoor Zarger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6208,
MSC 7804, Bethesda, MD 20892, (301) 435–
2477, [email protected].
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review

E:\FR\FM\02JNN1.SGM

02JNN1